State of Wisconsin Investment Board’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $539K | Buy |
14,886
+37
| +0.2% | +$1.26K | ﹤0.01% | 2072 |
|
|
2026
Q1 | $491K | Sell |
14,849
-27,145
| -65% | -$1.15M | ﹤0.01% | 2008 |
|
|
2025
Q4 | $1.94M | Buy |
41,994
+840
| +2% | +$35.1K | ﹤0.01% | 1422 |
|
|
2025
Q3 | $1.44M | Buy |
41,154
+25,060
| +156% | +$871K | ﹤0.01% | 1479 |
|
|
2025
Q2 | $476K | Sell |
16,094
-4,178
| -21% | -$119K | ﹤0.01% | 1890 |
|
|
2025
Q1 | $605K | Sell |
20,272
-20,616
| -50% | -$630K | ﹤0.01% | 1678 |
|
|
2024
Q4 | $1.17M | Sell |
40,888
-24,017
| -37% | -$795K | ﹤0.01% | 1461 |
|
|
2024
Q3 | $2.51M | Buy |
64,905
+400
| +0.6% | +$14.3K | 0.01% | 1223 |
|
|
2024
Q2 | $2.08M | Sell |
64,505
-9,832
| -13% | -$341K | 0.01% | 1273 |
|
|
2024
Q1 | $2.89M | Buy |
74,337
+13,669
| +23% | +$478K | 0.01% | 1138 |
|
|
2023
Q4 | $1.87M | Buy |
60,668
+33,277
| +121% | +$834K | 0.01% | 1249 |
|
|
2023
Q3 | $612K | Sell |
27,391
-1,299
| -5% | -$29.6K | ﹤0.01% | 1628 |
|
|
2023
Q2 | $617K | Sell |
28,690
-492
| -2% | -$11.2K | ﹤0.01% | 1727 |
|
|
2023
Q1 | $700K | Sell |
29,182
-3,362
| -10% | -$89.2K | ﹤0.01% | 1678 |
|
|
2022
Q4 | $755K | Buy |
32,544
+725
| +2% | +$14.6K | ﹤0.01% | 1675 |
|
|
2022
Q3 | $510K | Sell |
31,819
-1,902
| -6% | -$33.5K | ﹤0.01% | 1971 |
|
|
2022
Q2 | $598K | Sell |
33,721
-15,179
| -31% | -$255K | ﹤0.01% | 1983 |
|
|
2022
Q1 | $996K | Hold |
48,900
| – | – | ﹤0.01% | 1643 |
|
|
2021
Q4 | $913K | Hold |
48,900
| – | – | ﹤0.01% | 1481 |
|
|
2021
Q3 | $965K | Hold |
48,900
| – | – | ﹤0.01% | 1452 |
|
|
2021
Q2 | $1.16M | Hold |
48,900
| – | – | ﹤0.01% | 1409 |
|
|
2021
Q1 | $1.16M | Sell |
48,900
-9,200
| -16% | -$219K | ﹤0.01% | 1328 |
|
|
2020
Q4 | $1.16M | Sell |
58,100
-13,900
| -19% | -$271K | ﹤0.01% | 1289 |
|
|
2020
Q3 | $1.5M | Buy |
72,000
+17,000
| +31% | +$307K | ﹤0.01% | 1211 |
|
|
2020
Q2 | $962K | Sell |
55,000
-1,100
| -2% | -$21.5K | ﹤0.01% | 1245 |
|
|
2020
Q1 | $916K | Buy |
56,100
+7,900
| +16% | +$163K | ﹤0.01% | 1219 |
|
|
2019
Q4 | $992K | Hold |
48,200
| – | – | ﹤0.01% | 1240 |
|
|
2019
Q3 | $553K | Buy |
48,200
+7,900
| +20% | +$90.2K | ﹤0.01% | 1290 |
|
|
2019
Q2 | $530K | Buy |
40,300
+900
| +2% | +$12K | ﹤0.01% | 1308 |
|
|
2019
Q1 | $597K | Buy |
39,400
+9,000
| +30% | +$144K | ﹤0.01% | 1302 |
|
|
2018
Q4 | $522K | Buy |
30,400
+500
| +2% | +$8.55K | ﹤0.01% | 1301 |
|
|
2018
Q3 | $441K | Hold |
29,900
| – | – | ﹤0.01% | 1425 |
|
|
2018
Q2 | $713K | Buy |
29,900
+11,900
| +66% | +$293K | ﹤0.01% | 1284 |
|
|
2018
Q1 | $460K | Hold |
18,000
| – | – | ﹤0.01% | 1318 |
|
|
2017
Q4 | $332K | Hold |
18,000
| – | – | ﹤0.01% | 1348 |
|
|
2017
Q3 | $189K | Hold |
18,000
| – | – | ﹤0.01% | 1402 |
|
|
2017
Q2 | $225K | Buy |
+18,000
| New | +$178K | ﹤0.01% | 1396 |
|
Other funds holding COLL
JT
EAM
State of Wisconsin Investment Board's COLL Position: Q2 2026 in Review
State of Wisconsin Investment Board increased its Collegium Pharmaceutical (COLL) stake by 0.25% in Q2 2026, buying an estimated $1.26K and bringing the position to 14,886 shares worth $539K. The position accounts for ﹤0.01% of the portfolio, ranked #2072.
State of Wisconsin Investment Board first reported a position in COLL in Q2 2017 and has held it in 37 quarters since. The position peaked at $2.89M in Q1 2024. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.
- State of Wisconsin Investment Board held 14,886 shares of Collegium Pharmaceutical worth $539K as of Q2 2026.
- State of Wisconsin Investment Board bought 37 Collegium Pharmaceutical shares in Q2 2026, an estimated $1.26K.
- Collegium Pharmaceutical made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #2072 holding.
- State of Wisconsin Investment Board first reported a position in Collegium Pharmaceutical in Q2 2017 and has held it in 37 quarters since.
- State of Wisconsin Investment Board's Collegium Pharmaceutical position peaked at $2.89M in Q1 2024.
- 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.
Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.